rs1057517785
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001368894.2(PAX6):c.991C>T(p.Arg331*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000684 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001368894.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAX6 | NM_001368894.2 | c.991C>T | p.Arg331* | stop_gained | Exon 12 of 14 | ENST00000640368.2 | NP_001355823.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727248
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Aniridia 1 Pathogenic:2
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000372444 /PMID: 8111379). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate that R317X results in reduced activation of reporter genes compared to wild type (Chauhan et al., 2004); Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 26661695, 12868034, 21850189, 19898691, 25525159, 14744876, 27381094, 8111379, 27081561, 29901133, 12634864, 32360764, 34101622, 21397818, 15020706) -
PAX6: PVS1, PP1:Strong, PS2, PM2, PS4:Moderate, PS3:Supporting -
Albinism or congenital nystagmus Pathogenic:1
- -
Aniridia 1;C0344559:Irido-corneo-trabecular dysgenesis Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg317*) in the PAX6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAX6 are known to be pathogenic (PMID: 12634864). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with aniridia (PMID: 8111279, 19898691, 21397818, 22692063, 26661695). ClinVar contains an entry for this variant (Variation ID: 372444). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at